New paper could put CRISPR biotechs under pressure – FierceBiotech
FierceBiotech |
New paper could put CRISPR biotechs under pressure
FierceBiotech 5; Editas was down 0.7% afterhours Friday (and will be presenting at J.P. Morgan later this week), with Intellia down 2.7%, although CRISPR was slightly up by 0.3% afterhours, but had been up around 12% in normal hours trading. The authors conclude … |
